相似文献
1
Topical nonsteroidal anti-inflammatory drugs for macular edema.
Mediators Inflamm. 2013;2013:476525. doi: 10.1155/2013/476525. Epub 2013 Oct 21.
2
Efficacy and vitreous levels of topical NSAIDs.
Expert Opin Drug Deliv. 2015;12(11):1767-82. doi: 10.1517/17425247.2015.1068756. Epub 2015 Jul 14.
3
Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases.
Prostaglandins Other Lipid Mediat. 2021 Oct;156:106578. doi: 10.1016/j.prostaglandins.2021.106578. Epub 2021 Jul 7.
4
Nonsteroidal anti-inflammatory drugs in ophthalmology.
Surv Ophthalmol. 2010 Mar-Apr;55(2):108-33. doi: 10.1016/j.survophthal.2009.07.005.
5
Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review.
Ophthalmology. 2014 Oct;121(10):1915-24. doi: 10.1016/j.ophtha.2014.04.035. Epub 2014 Jun 14.
6
Perioperative Topical Nonsteroidal Anti-inflammatory Drugs for Macular Edema Prophylaxis Following Cataract Surgery.
Am J Ophthalmol. 2017 Apr;176:174-182. doi: 10.1016/j.ajo.2017.01.006. Epub 2017 Jan 17.
7
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery.
Expert Opin Pharmacother. 2018 Oct;19(14):1551-1563. doi: 10.1080/14656566.2018.1516206. Epub 2018 Sep 5.
8
Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane.
Korean J Ophthalmol. 2017 Oct;31(5):394-401. doi: 10.3341/kjo.2016.0109. Epub 2017 Aug 18.
9
Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.
Int Ophthalmol. 2017 Oct;37(5):1127-1131. doi: 10.1007/s10792-016-0374-5. Epub 2016 Oct 20.
10
Topical Nonsteroidal Anti-inflammatory Drugs for Cystoid Macular Edema Prevention in Patients With Diabetic Retinopathy.
Am J Ophthalmol. 2017 Sep;181:xiv-xvi. doi: 10.1016/j.ajo.2017.07.019. Epub 2017 Aug 1.
引用本文的文献
1
Indomethacin-incorporated microemulsion-laden contact lenses for improved ocular drug delivery and therapeutic efficacy.
RSC Adv. 2025 May 14;15(20):16110-16124. doi: 10.1039/d5ra01046b. eCollection 2025 May 12.
2
Radial Peripapillary Capillary Vessel Density as a New Biomarker in Pseudophakic Cystoid Macular Edema.
J Clin Med. 2025 Feb 21;14(5):1454. doi: 10.3390/jcm14051454.
3
Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review.
Life (Basel). 2024 Jun 3;14(6):725. doi: 10.3390/life14060725.
4
Short-Term Effects of Adding Topical Ketorolac to Intravitreal Bevacizumab in Diabetic Macular Edema: A Crossover Randomized Clinical Trial.
J Ophthalmic Vis Res. 2024 Mar 14;19(1):25-32. doi: 10.18502/jovr.v19i1.15424. eCollection 2024 Jan-Mar.
5
Aspirin intake is not associated with diabetic retinopathy and diabetic macular edema: A report from the Fushun diabetic retinopathy cohort study.
Indian J Ophthalmol. 2024 Feb 1;72(Suppl 2):S298-S302. doi: 10.4103/IJO.IJO_2932_23. Epub 2024 Jan 25.
6
Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular Angiogenesis.
Ophthalmol Sci. 2022 Sep;2(3). doi: 10.1016/j.xops.2022.100163. Epub 2022 Apr 20.
7
The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers.
Int J Mol Sci. 2022 Jul 8;23(14):7585. doi: 10.3390/ijms23147585.
8
A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC).
Ann Med. 2022 Dec;54(1):1977-1987. doi: 10.1080/07853890.2022.2098375.
9
Progressive resolution of exudation from perifoveal vascular anomalous complex: A possible role of diclofenac therapy?
Am J Ophthalmol Case Rep. 2022 Mar 5;26:101472. doi: 10.1016/j.ajoc.2022.101472. eCollection 2022 Jun.
10
A manually made needle for treating Pseudophakic cystoid macular edema by injecting triamcinolone acetonide in the suprachoroidal space: A case report.
Am J Ophthalmol Case Rep. 2021 Dec 31;25:101254. doi: 10.1016/j.ajoc.2021.101254. eCollection 2022 Mar.
本文引用的文献
1
A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration.
Br J Ophthalmol. 2013 Oct;97(10):1273-6. doi: 10.1136/bjophthalmol-2013-303417. Epub 2013 Jul 19.
2
Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.
JAMA Ophthalmol. 2013 Aug;131(8):1033-40. doi: 10.1001/jamaophthalmol.2013.4154.
3
Aqueous flare is increased in patients with clinically significant cystoid macular oedema after cataract surgery.
Br J Ophthalmol. 2013 Jul;97(7):862-5. doi: 10.1136/bjophthalmol-2012-302995. Epub 2013 Apr 23.
4
Nonsteroidal anti-inflammatory drugs for retinal disease.
Int J Inflam. 2013;2013:281981. doi: 10.1155/2013/281981. Epub 2013 Jan 14.
5
The association of aspirin use with age-related macular degeneration.
JAMA Intern Med. 2013 Feb 25;173(4):258-64. doi: 10.1001/jamainternmed.2013.1583.
6
24-hour intraocular pressure and ocular perfusion pressure in glaucoma.
Surv Ophthalmol. 2013 Jan-Feb;58(1):26-41. doi: 10.1016/j.survophthal.2012.05.003.
7
Mechanism of inflammation in age-related macular degeneration.
Mediators Inflamm. 2012;2012:546786. doi: 10.1155/2012/546786. Epub 2012 Nov 7.
8
Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.
Invest Ophthalmol Vis Sci. 2012 Aug 27;53(9):5906-11. doi: 10.1167/iovs.12-10410.
9
Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
J Cataract Refract Surg. 2012 Sep;38(9):1537-43. doi: 10.1016/j.jcrs.2012.04.034. Epub 2012 Jul 15.
10
Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration.
Retina. 2012 Oct;32(9):1804-10. doi: 10.1097/IAE.0b013e31825be87f.
Zotero 插件